TFF Pharmaceuticals
| General Information | |
| Business: |
We are an early-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on our patented Thin Film Freezing, or TFF, technology platform. We believe, and early testing confirms, that our TFF platform can significantly improve the solubility of poorly water-soluble drugs, a class of drugs that makes up approximately 33% of the major pharmaceuticals worldwide, thereby improving the pharmacokinetic effect of those drugs. |
| Industry: | PHARMACEUTICAL PREPARATIONS |
| Employees: | 7 |
| Founded: | 2018 |
| Contact Information | |
| Address | 2600 Via Fortuna, Suite 360, Austin, TX 78746, US |
| Phone Number | (737) 802-1973 |
| Web Address | http://www.tffpharma.com |
| View Prospectus: | TFF Pharmaceuticals |
| Financial Information | |
| Market Cap | $89.1mil |
| Revenues | $0 mil (last 12 months) |
| Net Income | $-5.9 mil (last 12 months) |
| IPO Profile | |
| Symbol | TFFP |
| Exchange | NASDAQ |
| Shares (millions): | 4.4 |
| Price range | $5.00 - $5.00 |
| Est. $ Volume | $22.0 mil |
| Manager / Joint Managers | National Securities |
| CO-Managers | - |
| Expected To Trade: | 10/25/2019 |
| Status: | Priced |
| Quiet Period Expiration Date: | Available only to Subscribers |
| Lock-Up Period Expiration Date: | Available only to Subscribers |
| SCOOP Rating | Available only to Subscribers |
| Rating Change | Available only to Subscribers |